We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 556 results
  1. Acid ceramidase targeting pyruvate kinase affected trypsinogen activation in acute pancreatitis

    Background

    Acute pancreatitis is the sudden inflammation of the pancreas. Severe cases of acute pancreatitis are potentially fatal and have no...

    Juan **ao, Wenying Zeng, ... Qiangqiang Fang in Molecular Medicine
    Article Open access 06 September 2022
  2. rAAV-mediated over-expression of acid ceramidase prevents retinopathy in a mouse model of Farber lipogranulomatosis

    Farber disease (FD) is a rare monogenic lysosomal storage disorder caused by mutations in ASAH1 that results in a deficiency of acid ceramidase...

    Hanmeng Zhang, Murtaza S. Nagree, ... Daniel M. Lipinski in Gene Therapy
    Article 28 July 2022
  3. Bioinformatics Analysis of Functional SNPs in Human ASAH1 Gene Related to Farber Disease

    Abstract

    Farber disease is a rare lysosomal storage disorder resulted from mutations in the ASAH1 gene codes acid ceramidase. The present study aimed...

    Article 09 February 2022
  4. Controlling Immunoregulatory Cell Activity for Effective Photodynamic Therapy of Cancer

    Recently, it has become clear that a prerequisite requirement for most cancer therapies is controlling the negative impact of the activity of...
    Mladen Korbelik, Zdzislaw M. Szulc, ... Duska Separovic in Photodynamic Therapy
    Protocol 2022
  5. PAQR8 promotes breast cancer recurrence and confers resistance to multiple therapies

    Background

    Breast cancer mortality is principally due to recurrent disease that becomes resistant to therapy. We recently identified copy number (CN)...

    Saisai Chen, Matt R. Paul, ... Lewis A. Chodosh in Breast Cancer Research
    Article Open access 03 January 2023
  6. Stress induces major depressive disorder by a neutral sphingomyelinase 2-mediated accumulation of ceramide-enriched exosomes in the blood plasma

    Abstract

    Major depressive disorder (MDD) is a very common, severe disease with a lifetime prevalence of ~ 10%. The pathogenesis of MDD is unknown and,...

    Fabian Schumacher, Alexander Carpinteiro, ... Erich Gulbins in Journal of Molecular Medicine
    Article Open access 31 August 2022
  7. A dominant negative ADIPOQ mutation in a diabetic family with renal disease, hypoadiponectinemia, and hyperceramidemia

    Adiponectin, encoded by ADIPOQ , is an insulin-sensitizing, anti-inflammatory, and renoprotective adipokine that activates receptors with intrinsic...

    Christopher A. Simeone, Joseph L. Wilkerson, ... Marcus G. Pezzolesi in npj Genomic Medicine
    Article Open access 22 July 2022
  8. ACER3-related leukoencephalopathy: expanding the clinical and imaging findings spectrum due to novel variants

    Background

    Leukodystrophies are the main subgroup of inherited CNS white matter disorders which cause significant mortality and morbidity in early...

    Ali Zare Dehnavi, Erfan Heidari, ... Ali Reza Tavasoli in Human Genomics
    Article Open access 19 July 2021
  9. Neuronal Ganglioside and Glycosphingolipid (GSL) Metabolism and Disease

    Glycosphingolipids (GSLs) are a diverse group of membrane components occurring mainly on the surfaces of mammalian cells. They and their metabolites...
    Roger Sandhoff, Konrad Sandhoff in Glycobiology of the Nervous System
    Chapter 2023
  10. Functional roles of sphingolipids in immunity and their implication in disease

    Sphingolipids, which are components of cellular membranes and organ tissues, can be synthesized or degraded to modulate cellular responses according...

    Mingyu Lee, Suh Yeon Lee, Yoe-Sik Bae in Experimental & Molecular Medicine
    Article Open access 01 June 2023
  11. Manifold Roles of Ceramide Metabolism in Non-Alcoholic Fatty Liver Disease and Liver Cancer

    Non-alcoholic fatty liver disease (NAFLD) is a metabolic disorder manifested in hepatic fat accumulation (hepatic steatosis) in the absence of heavy...
    Kai Wang, Yiran Wei, ... Cungui Mao in Sphingolipid Metabolism and Metabolic Disease
    Chapter 2022
  12. Sphingolipid Metabolism in Cancer: Potential Therapeutic Target

    Sphingolipids, particularly their two main bioactive metabolites ceramide and sphingosine-1-phosphate (S1P), play a key role in cancer death and...
    Mohamad Bahij Moumneh, Tarek Bou Dargham, ... Ghassan Dbaibo in Handbook of Cancer and Immunology
    Living reference work entry 2023
  13. Sphingolipids in Adipose: Kin or Foe?

    Obesity research has shifted in recent years to address not only the total amount of adipose tissue present in an individual but also to include...
    Yolander Valentine, L. Ashley Cowart in Sphingolipid Metabolism and Metabolic Disease
    Chapter 2022
  14. Neutral Ceramidase

    Motohiro Tani, Makoto Ito in Encyclopedia of Signaling Molecules
    Reference work entry 2018
  15. Lipidomics Analysis Reveals a Protective Effect of Myriocin on Cerebral Ischemia/Reperfusion Model Rats

    Ceramide accumulation has been associated with ischemic stroke. Myriocin is an effective serine palmitoyltransferase (SPT) inhibitor that reduces...

    Ting Wang, **gmin Zhang, ... Ying Li in Journal of Molecular Neuroscience
    Article 01 July 2022
  16. Genetic Tools for Studying the Roles of Sphingolipids in Viral Infections

    Sphingolipids are a critical family of membrane lipids with diverse functions in eukaryotic cells, and a growing body of literature supports that...
    Gaelen Guzman, Cameron Creek, ... Fikadu G. Tafesse in Virus-Host Interactions
    Protocol 2023
  17. Regulation of macrophage polarization by targeted metabolic reprogramming for the treatment of lupus nephritis

    Lupus nephritis (LN) is a severe and common manifestation of systemic lupus erythematosus (SLE) that is frequently identified with a poor prognosis....

    Limei Zhao, Shuqin Tang, ... **aoshuang Zhou in Molecular Medicine
    Article Open access 25 June 2024
  18. Sphingosine 1-Phosphate Lyase in the Develo** and Injured Nervous System: a Dichotomy?

    Sphingosine 1-phosphate lyase (SPL) is the terminal enzyme that controls the degradation of the bioactive lipid sphingosine 1-phosphate (S1P) within...

    Junhua **ao in Molecular Neurobiology
    Article Open access 28 July 2023
Did you find what you were looking for? Share feedback.